ArticleFrontiers in immunology2025
Identification and validation of glycosylation-related gene signatures for prognostic stratification in sepsis.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sepsis is a life-threatening condition caused by a dysregulated host response to infection and is one of the leading causes of morbidity and mortality worldwide. Glycosylation is one of the key modes of protein modification, affecting protein folding, transportation, and localization. Glycosylation patterns are closely related to sepsis, but their specific impact still needs further investigation. This study explored the role of glycosylation-related genes in sepsis through bioinformatics analysis and machine learning, and validated the expression value of the key genes. We identified 38 differentially expressed glycosylation-related genes in sepsis datasets, which divided sepsis patients into two subgroups with different survival outcomes, thus highlighting their prognostic value. Subsequently, we constructed prognostic models using various machine learning methods, classifying patients into high-risk and low-risk groups with significantly different survival rates. We conducted biological analysis of the key genes in the model at the single-cell level and also validated the expression of these key genes in sepsis patient samples. Our study not only enhances the understanding of sepsis glycosylation but also provides a new strategy for clinical diagnosis and prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.